{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:23:00Z","timestamp":1790716980440,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005010","name":"AIRC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Pharmacology"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.coph.2016.08.001","type":"journal-article","created":{"date-parts":[[2016,8,21]],"date-time":"2016-08-21T00:32:28Z","timestamp":1471739548000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Different molecular signaling sustaining adiponectin action in breast cancer"],"prefix":"10.1016","volume":"31","author":[{"given":"Maria Luisa","family":"Panno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina Daniela","family":"Naimo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Spina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastiano","family":"And\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loredana","family":"Mauro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coph.2016.08.001_sbref0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.cytogfr.2016.03.014","article-title":"The role of adiponectin in obesity-associated female-specific carcinogenesis","author":"Nagaraju","year":"2016","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.coph.2016.08.001_bib0010","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/90984","article-title":"The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity","volume":"7","author":"Yamauchi","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.coph.2016.08.001_bib0015","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/90992","article-title":"The adipocyte-secreted protein Acrp30 enhances hepatic insulin action","volume":"7","author":"Berg","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.coph.2016.08.001_sbref0020","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1146\/annurev-pathol-012615-044359","article-title":"Obesity, Inflammation and cancer","volume":"11","author":"Deng","year":"2016","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.coph.2016.08.001_bib0025","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1100\/2011\/806787","article-title":"Obesity, inflammation, and postmenopausal breast cancer: therapeutic implications","volume":"11","author":"Macci\u00f2","year":"2011","journal-title":"Sci World J"},{"key":"10.1016\/j.coph.2016.08.001_bib0030","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1006\/bbrc.2001.5815","article-title":"Estradiol increases IRS-1 gene expression and insulin signaling in breast cancer cells","volume":"288","author":"Mauro","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.coph.2016.08.001_bib0035","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1210\/er.2011-1015","article-title":"The role of adiponectin in cancer: a review of current evidence","volume":"33","author":"Dalamaga","year":"2012","journal-title":"Endocr Rev"},{"key":"10.1016\/j.coph.2016.08.001_bib0040","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.2337\/diacare.26.8.2442","article-title":"Adiponectin: more than just another fat cell hormone?","volume":"26","author":"Chandran","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.coph.2016.08.001_bib0045","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1210\/jc.2003-031804","article-title":"Adiponectin and breast cancer risk","volume":"89","author":"Mantzoros","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.coph.2016.08.001_bib0050","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1210\/jc.2002-021209","article-title":"Plasma adiponectin concentrations in relation to endometrial cancer: a case-control study in Greece","volume":"88","author":"Petridou","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.coph.2016.08.001_bib0055","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.urology.2004.12.053","article-title":"Prostate cancer and adiponectin","volume":"65","author":"Goktas","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.coph.2016.08.001_bib0060","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1158\/1078-0432.466.11.2","article-title":"Plasma adiponectin and gastric cancer","volume":"11","author":"Ishikawa","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.coph.2016.08.001_bib0065","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1002\/ijc.25861","article-title":"Serum level of adiponectin and the risk of liver cancer development in chronic hepatitis C patients","volume":"129","author":"Arano","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1016\/j.coph.2016.08.001_bib0070","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1093\/aje\/kwn221","article-title":"Prediagnostic adiponectin concentrations and pancreatic cancer risk in male smokers","volume":"168","author":"Stolzenberg-Solomon","year":"2008","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.coph.2016.08.001_bib0075","doi-asserted-by":"crossref","first-page":"5049","DOI":"10.1200\/JCO.2008.19.7525","article-title":"Serum adiponectin as a predictor of childhood non-Hodgkin's lymphoma: a nationwide case-control study","volume":"27","author":"Petridou","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.coph.2016.08.001_bib0080","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/sj.bjc.6602896","article-title":"Adiponectin in relation to childhood myeloblastic leukaemia","volume":"94","author":"Petridou","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.coph.2016.08.001_bib0085","doi-asserted-by":"crossref","first-page":"10697","DOI":"10.1074\/jbc.271.18.10697","article-title":"AdipoQ is a novel adipose-specific gene dysregulated in obesity","volume":"271","author":"Hu","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coph.2016.08.001_bib0090","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/sj.ijo.0801244","article-title":"Genomic structure and mutations in adipose-specific gene, adiponectin","volume":"24","author":"Takahashi","year":"2000","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.coph.2016.08.001_bib0095","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.2337\/diabetes.51.7.2306","article-title":"A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome","volume":"51","author":"Menzaghi","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.coph.2016.08.001_bib0100","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1158\/0008-5472.CAN-08-0533","article-title":"Variants of the adiponectin and adiponectin receptor 1 genes and breast cancer risk","volume":"68","author":"Kaklamani","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.coph.2016.08.001_bib0105","doi-asserted-by":"crossref","first-page":"422S","DOI":"10.3945\/jn.114.202432","article-title":"The role of adiponectin in cardiometabolic diseases: effects of nutritional interventions","volume":"146","author":"Lopez-Jaramillo","year":"2016","journal-title":"J Nutr"},{"key":"10.1016\/j.coph.2016.08.001_sbref0110","doi-asserted-by":"crossref","first-page":"e0129246","DOI":"10.1371\/journal.pone.0129246","article-title":"Circulating High-Molecular-Weight (HMW) adiponectin level is related with breast cancer risk better than total adiponectin: a Case-Control study","volume":"10","author":"Guo","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.coph.2016.08.001_bib0115","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12020-009-9278-8","article-title":"Adiponectin action from head to toe","volume":"37","author":"Brochu-Gaudreau","year":"2010","journal-title":"Endocrine"},{"key":"10.1016\/j.coph.2016.08.001_bib0120","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/nature14301","article-title":"Crystal structures of the human adiponectin receptors","volume":"520","author":"Tanabe","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.coph.2016.08.001_bib0125","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1210\/er.2005-0005","article-title":"Adiponectin and adiponectin receptors","volume":"26","author":"Kadowaki","year":"2005","journal-title":"Endocr Rev"},{"key":"10.1016\/j.coph.2016.08.001_bib0130","doi-asserted-by":"crossref","first-page":"10308","DOI":"10.1073\/pnas.0403382101","article-title":"T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30\/adiponectin","volume":"101","author":"Hug","year":"2004","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.coph.2016.08.001_bib0135","doi-asserted-by":"crossref","first-page":"4342","DOI":"10.1172\/JCI43464","article-title":"T-cadherin is critical for adiponectin-mediated cardioprotection in mice","volume":"120","author":"Denzel","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coph.2016.08.001_bib0140","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrc2676","article-title":"The LKB1-AMPK pathway: metabolism and growth control in tumour suppression","volume":"9","author":"Shackelford","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.coph.2016.08.001_sbref0145","doi-asserted-by":"crossref","first-page":"101","DOI":"10.20892\/j.issn.2095-3941.2015.0092","article-title":"Evolving role of adiponectin in cancer-controversies and update","volume":"13","author":"Katira","year":"2016","journal-title":"Cancer Biol Med"},{"key":"10.1016\/j.coph.2016.08.001_bib0150","first-page":"2085","article-title":"The tumor suppressor gene LKB1 is associated with prognosis in human breast carcinoma","volume":"8","author":"Shen","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.coph.2016.08.001_bib0155","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev.biochem.75.103004.142702","article-title":"LKB1-dependent signaling pathways","volume":"75","author":"Alessi","year":"2006","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.coph.2016.08.001_bib0160","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1093\/emboj\/cdg292","article-title":"Activation of the tumour suppressor kinase LKB1 by the STE20-like pseudokinase STRAD","volume":"22","author":"Baas","year":"2003","journal-title":"EMBO J"},{"key":"10.1016\/j.coph.2016.08.001_bib0165","doi-asserted-by":"crossref","first-page":"5102","DOI":"10.1093\/emboj\/cdg490","article-title":"MO25alpha\/beta interact with STRADalpha\/beta enhancing their ability to bind, activate and localize LKB1 in the cytoplasm","volume":"22","author":"Boudeau","year":"2003","journal-title":"EMBO J"},{"key":"10.1016\/j.coph.2016.08.001_bib0170","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3389\/fonc.2015.00157","article-title":"Cross-talk between adiponectin and IGF-IR in breast cancer","volume":"5","author":"Mauro","year":"2015","journal-title":"Front Oncol"},{"key":"10.1016\/j.coph.2016.08.001_bib0175","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1158\/1541-7786.MCR-06-0118","article-title":"Enhanced expression of LKB1 in breast cancer cells attenuates angiogenesis, invasion, and metastatic potential","volume":"4","author":"Zhuang","year":"2006","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.coph.2016.08.001_bib0180","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.tips.2004.12.011","article-title":"AMPK, the metabolic syndrome and cancer","volume":"26","author":"Luo","year":"2005","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.coph.2016.08.001_bib0185","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1748-1716.2009.01972.x","article-title":"LKB1 and AMP-activated protein kinase control of mTOR signalling and growth","volume":"196","author":"Shaw","year":"2009","journal-title":"Acta Physiol (Oxf)"},{"key":"10.1016\/j.coph.2016.08.001_bib0190","first-page":"213","article-title":"Role of adiponectin and its receptors in cancer","volume":"9","author":"Obeid","year":"2012","journal-title":"Cancer Biol Med"},{"key":"10.1016\/j.coph.2016.08.001_bib0195","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S1097-2765(02)00568-3","article-title":"Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase\/akt pathway","volume":"10","author":"Manning","year":"2002","journal-title":"Mol Cell"},{"key":"10.1016\/j.coph.2016.08.001_bib0200","doi-asserted-by":"crossref","first-page":"R785","DOI":"10.1016\/S0960-9822(02)01294-0","article-title":"Growth signaling: TSC takes its place","volume":"12","author":"Marygold","year":"2002","journal-title":"Curr Biol"},{"key":"10.1016\/j.coph.2016.08.001_bib0205","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ctrv.2003.07.007","article-title":"PI3K\/Akt signaling pathway and cancer","volume":"30","author":"Fresno Vara","year":"2004","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.coph.2016.08.001_bib0210","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.bbrc.2006.04.076","article-title":"Adiponectin mediates antiproliferative and apoptotic responses in human MCF7 breast cancer cells","volume":"345","author":"Dieudonne","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.coph.2016.08.001_bib0215","doi-asserted-by":"crossref","first-page":"11462","DOI":"10.1158\/0008-5472.CAN-06-1969","article-title":"Adiponectin modulates the glycogen synthase kinase-3beta\/beta-catenin signaling pathway and attenuates mammary tumorigenesis of MDA-MB-231 cells in nude mice","volume":"66","author":"Wang","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.coph.2016.08.001_bib0220","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/BF02978210","article-title":"Adiponectin induces growth arrest and apoptosis of MDA-MB-231 breast cancer cell","volume":"28","author":"Kang","year":"2005","journal-title":"Arch Pharm Res"},{"key":"10.1016\/j.coph.2016.08.001_bib0225","first-page":"971","article-title":"Adiponectin mediates an antiproliferative response in human MDA-MB 231 breast cancer cells","volume":"20","author":"Dos Santos","year":"2008","journal-title":"Oncol Rep"},{"key":"10.1016\/j.coph.2016.08.001_bib0230","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/sj.bjc.6604166","article-title":"Effects of adiponectin on breast cancer cell growth and signaling","volume":"98","author":"Grossmann","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.coph.2016.08.001_bib0235","first-page":"787","article-title":"Adiponectin effects on human breast cancer cells are dependent on 17-beta estradiol","volume":"19","author":"Pfeiler","year":"2008","journal-title":"Oncol Rep"},{"key":"10.1016\/j.coph.2016.08.001_bib0240","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1158\/1078-0432.CCR-08-2649","article-title":"Proangiogenic contribution of adiponectin toward mammary tumor growth in vivo","volume":"15","author":"Landskroner-Eiger","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.coph.2016.08.001_sbref0245","doi-asserted-by":"crossref","first-page":"553","DOI":"10.4161\/cc.27455","article-title":"Evidences that estrogen receptor \u03b1 interferes with adiponectin effects on breast cancer cell growth","volume":"13","author":"Mauro","year":"2014","journal-title":"Cell Cycle"},{"key":"10.1016\/j.coph.2016.08.001_sbref0250","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1096\/fj.14-262808","article-title":"Estrogen receptor-\u03b1 drives adiponectin effects on cyclin D1 expression in breast cancer cells","volume":"29","author":"Mauro","year":"2015","journal-title":"FASEB J"},{"key":"10.1016\/j.coph.2016.08.001_bib0255","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1472-6750-11-90","article-title":"Design and development of a peptide-based adiponectin receptor agonist for cancer treatment","volume":"11","author":"Otvos","year":"2011","journal-title":"BMC Biotechnol"},{"key":"10.1016\/j.coph.2016.08.001_bib0260","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s10911-013-9302-8","article-title":"Leptin and adiponectin: emerging therapeutic targets in breast cancer","volume":"18","author":"Surmacz","year":"2013","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"10.1016\/j.coph.2016.08.001_sbref0265","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1515\/hmbci-2015-0007","article-title":"Molecular targeting of obesity pathways in cancer","volume":"22","author":"Surmacz","year":"2015","journal-title":"Horm Mol Biol Clin Investig"},{"key":"10.1016\/j.coph.2016.08.001_sbref0270","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/bip.22627","article-title":"Optimization of adiponectin-derived peptides for inhibition of cancer cell growth and signaling","volume":"104","author":"Otvos","year":"2015","journal-title":"Biopolymers"},{"key":"10.1016\/j.coph.2016.08.001_bib0275","doi-asserted-by":"crossref","first-page":"e63354","DOI":"10.1371\/journal.pone.0063354","article-title":"Identification of adiponectin receptor agonist utilizing a fluorescence polarization based high throughput assay","volume":"8","author":"Sun","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.coph.2016.08.001_bib0280","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.cytogfr.2013.10.001","article-title":"Role of adipokines and cytokines in obesity-associated breast cancer: therapeutic targets","volume":"24","author":"Khan","year":"2013","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.coph.2016.08.001_bib0285","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.canlet.2008.08.008","article-title":"PPARgamma independent antitumor effects of thiazolidinediones","volume":"276","author":"Wei","year":"2009","journal-title":"Cancer Lett"}],"container-title":["Current Opinion in Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489216300868?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489216300868?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T00:08:37Z","timestamp":1718755717000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471489216300868"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":57,"alternative-id":["S1471489216300868"],"URL":"https:\/\/doi.org\/10.1016\/j.coph.2016.08.001","relation":{},"ISSN":["1471-4892"],"issn-type":[{"value":"1471-4892","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Different molecular signaling sustaining adiponectin action in breast cancer","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coph.2016.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}